Investor Presentaiton
Eurofins is setting up a global network of clinical
genetics laboratories
* eurofins
Nowadays, Clinical Genetics is a central element in healthcare and Clinical Diagnostics, contributing to every stage of
patient care
Throughout all three of Eurofins' start-up programs, several large investments in global clinical genetics laboratories have
been made, giving Eurofins a unique portfolio of services for cutting-edge applications.
•
Eurofins, through acquisitions and start-up laboratories, is investing heavily in advanced technologies:
EGL
Predictive tests for
genetic diseases and
oncology
Side effects/efficacy
of drugs
•
Rare diseases testing
Non Invasive Prenatal Testing
Personalized medicine offering
patients individualized treatment
based on their genetic and metabolic
profiles
Next Generation Sequencing -Whole
Genome Sequencing
NTD
USA
Boston Heart
Europe
Developments in genetics and genomics will have a
significant impact on tomorrow's clinical diagnostics market
APAC
Vira Cor
Diatherix
Biomnis
Megalab
Lifecodexx
Genoma
Clinical Genetics Bangalore start-up
Clinical Genetics Tokyo start-up
Since 2014, Eurofins has already developed a network
of laboratories focused on clinical genetics in several
countries around the globe, including: India, Japan,
France, Germany, Spain, Italy and the USA
59View entire presentation